Grojaraštis ReachMD

21:47

001 5920123
21:44

001 5924329
21:43

001 5924781
21:42

001 5920362
21:38

001 5924423
21:33

001 5924485
21:31

001 5924817
21:20

Practical Risk Assessment for AKT Inhibitor 54762
21:19

001 5924922
21:15

001 5924062
21:02

Real 54336
20:55

001 5924855
20:54

001 5921112
20:01

Global Perspectives on New Data in Type 2 Diabetes 36231
19:58

001 5924037
19:54

001 5924790
19:50

001 5924080
19:44

001 5924849
19:36

001 5924792
19:22

36270 Audio 36270
19:21

001 5920363
19:16

001 5924860
19:03

Key CKD Updates from the 2026 NKF Meetings 49276
18:57

001 5924857
18:47

001 5924912
18:44

001 5924928
18:38

001 5924850
18:24

Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors 54388
18:23

001 5920361
18:11

When Is It Time to Move Beyond Topicals in Pediatric Atopic Dermatitis? 56679
17:55

001 5924514
17:49

001 5924956
17:43

001 5924851
17:38

001 5924929
17:32

001 5924913
17:22

56452 Podcast 56452
17:21

001 5924921
17:10

Practical Risk Assessment for AKT Inhibitor 54762
17:00

001 5924910
16:51

001 5924911
16:44

001 5924957
16:38

001 5924908
16:27

IL 51037
16:26

001 5924923
16:16

001 5924909
16:04

Personalizing Systemic Therapy in Atopic Dermatitis and Prurigo Nodularis 51039
15:03

Beyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management 49097
14:44

7708 allen green 10262015 7708
14:29

4599 Parker Hill 4599
14:15

12180 podcast 12180
14:00

7053 Pickard Silver 08252014 7053
13:54

001 5925040
13:44

001 5923389
13:30

The Mechanistic Case for Dual BAFF and APRIL Inhibition in IgAN 60616
13:25

001 5923475
13:21

001 5924187
13:16

001 5924015
13:04

Key CKD Updates from the 2026 NKF Meetings 49276
12:59

001 5924252
12:45

Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care 54800
12:41

001 5924063
12:36

001 5924488
12:31

001 5924036
12:25

001 5924486
12:14

56452 Podcast 56452
12:02

50890podcast 50890
11:46

29905 podcast 29905
11:41

001 5923391
11:36

001 5924492
11:33

001 5924578
11:32

001 5924923
11:27

001 5924825
11:12

Progress in Breast Cancer Care: Translating SABCS Data Into Practice 48989
10:58

Targeting B7 36232
10:44

Examining the Global Genetic Prevalence of TK2d 54413
10:38

001 5924955
10:33

001 5925036
10:20

Integrating Patient Perspectives in Dermatologic Care 37245
10:09

Practical Risk Assessment for AKT Inhibitor 54762
09:51

54582 podcast 54582
09:39

Hypertension Across Diverse Populations: Practical Strategies for Equitable Care 56369
08:37

36607 podcast v1 MM 36607
08:32

001 5924686
08:31

001 5920947
07:47

39877 audio 39877
07:42

001 5924017
07:28

36270 Audio 36270
07:23

001 5924813
06:59

Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real 35866
06:53

001 5924487
06:44

001 5925046
06:35

001 5924788
06:23

Case Consult: Personalizing First 60963
06:05

Rewriting the Calcium Code in ADH1 54833
05:55

Axatilimab's Impact on cGVHD and Associated BOS 54341
05:42

Key CKD Updates from the 2026 NKF Meetings 49276
05:40

001 5925049
05:39

001 5920139
05:33

001 5925058
05:27

001 5923849
05:24

001 5923848
05:20

001 5925057
05:09

56452 Podcast 56452
05:04

001 5925056
04:53

Practical Risk Assessment for AKT Inhibitor 54762
04:42

Real 54340
04:39

001 5924611
04:38

001 5920146
04:33

001 5924700
04:28

001 5924620
04:27

001 5924923
04:22

001 5923852
04:18

001 5924183
04:16

001 5924682
04:05

36271 Podcast 36271
04:00

001 5924494
03:45

36270 Audio 36270
03:41

001 5924649
03:38

001 5924807
03:37

001 5920361
03:30

001 5924721
03:26

001 5924195
03:17

001 5924809
03:00

Rewriting the Calcium Code in ADH1 54833
02:59

001 5924920
02:56

001 5924917
02:45

Axatilimab's Impact on cGVHD and Associated BOS 54341
02:40

001 5924215
02:35

001 5924497
02:32

001 5924193
02:27

001 5924619
02:26

001 5924922
02:21

001 5924824
02:09

Key CKD Updates from the 2026 NKF Meetings 49276
02:08

001 5924921
01:58

56452 Podcast 56452
01:47

Practical Risk Assessment for AKT Inhibitor 54762
01:42

001 5924718
01:31

Real 54340
01:26

001 5924393
01:03

36523 podcast 36523
00:59

001 5924222
00:45

36270 Audio 36270